VTVT:NASDAQ, vTv Therapeutics Inc.

VTVT stock overview

vTv Therapeutics Inc. (VTVT:NASDAQ) closed at $21.74 on November 5, 2026, down 9.53% on the day. The stock trades 50.6% below its 52-week high of $44.00 and 0.1% above its 52-week low of $21.72. Over the past year, it lost 14.6%. vTv Therapeutics Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$21.74
Day change
-9.53%
Volume
17,774
Average volume
43,540
Market cap
85M+
52-week range
$21.72 – $44.00
50-day average
$29.70
200-day average
$33.34

Price action over the past year

In 252 trading sessions since November 5, 2025, VTVT closed higher on 123 days (49%). Its best day was May 14, 2026 (+21.36%) and its worst was February 5, 2026 (-14.83%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

VTVT news

About vTv Therapeutics Inc.

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.

Similar stocks

Find more stocks like VTVT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.